908 Devices Inc.
NASDAQ:MASSMedical - Devices
+$0.22 today
- Market cap
- $395.86M
- Beta
- 0.64
- P/E (TTM)
- -9.0
- EPS (TTM)
- -$0.97
Volume 0.25M
Average 0.27M
MASS Operating Expenses
Total costs of running the business that are not directly tied to producing goods or services sold.
908 Devices Inc.NASDAQ: MASS
Operating Expenses · Q1 FY2026 · quarter ended Mar 2026
Operating expenses declines year over year
Q1 FY2026 operating expenses of $12.88M fell 22.2% year over year, ahead of the -36.9% change in trailing-twelve-month operating expenses. Sequentially, it rose 8.8% from the prior quarter. Over 3 fiscal years it compounded at -6.0% a year.
Context
- Operating expenses amounted to 90.7% of revenue in FY2025, down 88.1 pp from a year earlier.
- Operating expenses increased in 2 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of -22.2% holds above the trailing-twelve-month pace of -36.9%.
Sources:Income StatementText generated from reported figures; not investment advice.
Operating Expenses history
USD · from the income statement
- Latest · FY2025
- 50.98M USD
- Year-over-year change
- -52.2%
- 4-year CAGR
- +3.0%
| Period | Period end | Operating Expenses | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 50.98M | -52.2% |
| FY2024 | 2024-12-31 | 106.64M | +56.6% |
| FY2023 | 2023-12-31 | 68.08M | +10.9% |
| FY2022 | 2022-12-31 | 61.41M | +35.5% |
| FY2021 | 2021-12-31 | 45.3M | — |
Operating Expenses vs competitors
How MASS compares with its peers on the latest reported figures
- MASS's LTM Mar 2026 operating expenses of $58.67M is the lowest of the 3 companies compared; the peer median is $1.54B.
- Its year-over-year change of -36.9% is the lowest of 3, against a peer median of +0.9%.
- Operating expenses amounts to 101.5% of revenue for MASS, versus a peer median of 34.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jul 2026 | $2.32B | +7.9% | +0.9% | 31.5% | |
| LTM Jun 2026 | $766.43M | -6.1% | -3.3% | 36.5% | |
| LTM Mar 2026 | $58.67M | -36.9% | -6.0% | 101.5% | |
| Peer median (excluding MASS) | $1.54B | +0.9% | -1.2% | 34.0% | |
Competitors are the stored peer set for MASS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 42.21M | 46.85M | 50.23M | 59.63M | 56.2M |
| Cost of Revenue | 18.97M | 20.83M | 24.91M | 29.71M | 29.4M |
| Gross Profit | 23.23M | 26.02M | 25.32M | 29.93M | 26.8M |
| Gross Margin | 55.0% | 55.5% | 50.4% | 50.2% | 47.7% |
| Research & Development | 13.07M | 17.53M | 21.9M | 25.5M | 13.8M |
| Selling, General & Admin | 32.24M | 43.88M | 0 | 0 | 37.18M |
| Operating Expenses | 45.3M | 61.41M | 68.08M | 106.64M | 50.98M |
| Depreciation & Amortization | 925K | 1.61M | 2.38M | 4.68M | 4.47M |
| EBITDA | (20.76M) | (31.82M) | (40.27M) | (43.88M) | (28.88M) |
| EBITDA Margin | -49.2% | -67.9% | -80.2% | -73.6% | -51.4% |
| Operating Income | (22.07M) | (35.38M) | (42.76M) | (76.72M) | (24.18M) |
| Operating Margin | -52.3% | -75.5% | -85.1% | -128.7% | -43.0% |
| Interest Income | 548K | 2.03M | 6.48M | 4.49M | 4.14M |
| Interest Expense | 486K | 129K | 201K | 0 | 0 |
| Other Income / Expenses | (100K) | 1.82M | 6.15M | 4.23M | (9.16M) |
| Income Before Tax | (22.17M) | (33.56M) | (36.61M) | (72.49M) | (33.34M) |
| Pre-Tax Margin | -52.5% | -71.6% | -72.9% | -121.6% | -59.3% |
| Income Tax Expense | 0 | 0 | (211K) | (282K) | (66K) |
| Net Income | (22.17M) | (33.56M) | (36.4M) | (72.21M) | (36.64M) |
| Net Margin | -52.5% | -71.6% | -72.5% | -121.1% | -65.2% |
| EPS (Basic) | (0.79) | (1.07) | (1.13) | (2.12) | 0.54 |
| EPS (Diluted) | (0.79) | (1.07) | (1.13) | (2.12) | 0.54 |
| Weighted Avg Shares | 27.96M | 31.49M | 32.21M | 34.08M | 36.22M |
| Weighted Avg Shares (Diluted) | 27.96M | 31.49M | 32.24M | 34.08M | 38.92M |
908 Devices Inc.
NASDAQ:MASS
Intrinsic Alpha fair value
Locked
Current Price
$9.52
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.